Genelux (GNLX) Other Non-Current Assets (2022 - 2026)
Genelux (GNLX) recorded quarterly Other Non-Current Assets of $144000.0 in Q1 2026, little changed quarter-over-quarter from $144000.0 in Q4 2025.
Genelux (GNLX) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Genelux's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $144000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $144000.0; the TTM figure through Mar 2026 stood at $144000.0 (changed N/A YoY), while the FY2025 annual figure was $144000.0, up 56.52% from the prior year.
- Other Non-Current Assets was $144000.0 for Q1 2026 at Genelux, roughly flat from $144000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q3 2025 to a low of $73000.0 in Q2 2025.
- Historically, Other Non-Current Assets has averaged $182272.7 across 5 years, with a median of $92000.0 in 2022.
- Biggest YoY gain for Other Non-Current Assets was 986.96% in 2025; the steepest drop was 20.65% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $92000.0 in 2022, then changed by 0.0% to $92000.0 in 2023, then changed by 0.0% to $92000.0 in 2024, then soared by 56.52% to $144000.0 in 2025, then changed by 0.0% to $144000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $144000.0 (Q1 2026), $144000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 73,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 92,000.00 |
| Mar 31, 2024 | 92,000.00 |
| Dec 31, 2023 | 92,000.00 |
| Sep 30, 2023 | 92,000.00 |
| Dec 31, 2022 | 92,000.00 |